About Training Course

This course draws on the 20 years of experience Uppsala Monitoring Centre (UMC) has in providing education and training to a global network of Pharmacovigilance experts and healthcare professionals. The Asia Pacific course is tailored to regional needs and addresses challenges unique to this area.

The course is aimed at developing Pharmacovigilance knowledge and skills in the Asia Pacific region. Four Asia Pacific Pharmacovigilance training courses were successfully conducted during the last four years at JSS University, Mysuru. Healthcare professionals from 20 different countries participated and got benefited from the courses.

For the first time this highly informative training course is conducted at IPC, Ghaziabad, India, a WHO Collaborating Centre for Pharmacovigilance in public health programmes and regulatory services from 4th – 15th March 2019.

This course provides a solid practical foundation for those working in drug safety as well as the latest knowledge and thinking for experienced staff.

The course focuses on essential topics including:
• Pharmacovigilance best practices
• Signal detection
• Regulatory aspects
• Reporting culture
• Pharmacovigilance in public health
• Benefit/harm assessment
• Pharmacovigilance tools.

About Indian Pharmacopoeia Commission

The Indian Pharmacopoeia Commission (IPC) was established as an Autonomous Institution under the Ministry of Health & Family Welfare, Government of India, primarily with the objectives of regularly updating the Indian Pharmacopoeia (an official book of standards for drugs) by publishing new editions and its addenda, National Formulary of India (a reference book for rational use of medicines) besides providing IP Reference Substances/Impurity standards and training the stakeholders on pharmacopoeial issues. IPC is the first WHO prequalified Government Organization in India in the area of Physical and Chemical Analysis of Active Pharmaceutical Ingredients (APIs) and finished Pharmaceutical Products.

IPC functions as a National Coordination Centre (NCC) for Pharmacovigilance Programme of India (PvPI) and Materiovigilance Programme of India (MvPI) to safe guard the health of Indian Population. IPC is designated as a WHO-Collaborating Centre for Pharmacovigilance in Public Health Programme and Regulatory Services. For detailed information, please visit: http://www.ipc.gov.in/PvPI/pv_home.html.

About Uppsala Monitoring Centre

Uppsala Monitoring Centre (UMC) advances the science of pharmacovigilance and inspires patient safety initiatives all over the world.

As an independent, non-profit foundation, UMC engages stakeholders who share their vision and collaborates to build a global patient safety culture. As a leader in the research and development of new scientific methods, UMC explores the benefits and risks of medicines to help minimize harm to patients, and offers products and services used by health authorities and life-science companies worldwide. For almost 40 years, UMC has provided scientific leadership and operational support to the WHO Programme for International Drug Monitoring. For detailed information, please visit: https://www.who-umc.org/education-training/education-training

Copyright @2019 IPC - All Rights Reserved

for any query please contact us at: it.nccpvpi@gmail.com